Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Treprostinil in Fontan Patients
NCT02769624Phase 2Terminated
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Feb 2017
- Primary completion
- Sep 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of treprostinil in congenital heart disease (CHD), sponsored by Cincinnati Children's Hospital Medical Center. Started Feb 2017; status: terminated.
02
Drugs
treprostinil
03
Conditions
congenital heart disease (CHD)
Beyond the preview
Go deeper on NCT02769624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02769624.